# Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression

> **NCT05774665** · PHASE2 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 14 (actual)

## Conditions studied

- Treatment Resistant Depression
- Inflammation
- Overweight

## Interventions

- **DRUG:** Omega 3
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05774665
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-30
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05774665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05774665, "Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05774665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*